The efficacy of 2.5% phenylephrine and flurbiprofen combined in inducing and maintaining pupillary dilatation during cataract surgery

European Journal of Ophthalmology

Volumn 10, Issue 2, 2000, Pages 144-148

  Öztürk, Faruk ^a,b   Kurt, E ^a   Inan, U U ^a   Ilker, S S ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b Mh Cevat Sakir   (Turkey)

Author keywords

10 phenylephrine; 2.5 phenylephrine; Extracapsular cataract extraction (ECCE); Flurbiprofen; Mydriasis

Indexed keywords

CYCLOPENTOLATE; FLURBIPROFEN; PHENYLEPHRINE;

ARTICLE; CAPSULOTOMY; CATARACT EXTRACTION; DRUG EFFICACY; EXTRACAPSULAR CATARACT EXTRACTION; HUMAN; LENS IMPLANT; MYDRIASIS; PRIORITY JOURNAL; SURGICAL MICROSCOPE;

EID: 17044449801     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210001000209     Document Type: Article

References (28)

1. Guzek JP, Holm M, Cotter JB, et al. Risk factors for intraoperative complications in 1000 extracapsular cataract cases. Ophthalmology 1987; 94: 461-6.
2. Terasvirta M. Topical indomethacin in extracapsular cataract surgery. Acta Ophthalmol 1989; 67: 339-41.
3. Sachdev MS, Kirti Singh, Dinesh Talwar, Gupta SK, Dada VK. Comparative efficancy of diclofenac and flurbiprofen for maintenance of pupillary dilatation during cataract surgery. Ophthalmic Surg 1994; 25: 92-4.
4. Tanner V, Casswell AG. Comparative study of the efficacy of 2.5% phenylephrine and 10% phenylephrine in pre-operative mydriasis for routine cataract surgery. Eye 1996; 10: 95-8.
5. British National Formulary.London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 1994; 389-90.
6. The Association of British Pharmaceutical Industries Data Sheet Compendium. Datapharm Publications, 1994; 5: 1561-2.
7. Duffln RM, Pettit TH, Straatsma BR. 2.5% vs 10% phenylephrine in maintaining mydriasis during cataract surgery. Arch Ophthalmol 1983; 101: 1903-6.
8. Neuhaus RW, Helper RS. Mydriatic effect of phenylephrine 10% vs 2.5%. Ann Ophthalmol 1980; 12: 1159-60.
9. Chin KW, Law NM, Chin MK. Phenylephrine eye drops in ophthalmic surgery - a clinical study on cardiovascular effects. Med J Malaysia 1994; 49: 158-63.
10. Camras CB, Miranda OC. The putative role of prostaglandins in surgical miosis. In: Bito IZ, Stjernschantz J, eds. The ocular effects of prostaglandins and other eicosanoids. New York: Alan R, Liss lnc, 1989; 197-210.
11. Keates RH, Mc Gowan KA. The effect of topical indomethacin ophthalmic solution in maintaining mydriasis during cataract surgery. Ann Ophthalmol 1984; 16: 1116-21.
12. Kulkarinin PS. Synthesis of cyclooxygenase products by human anterior uvea from cyclic prostaglandin endoperoxidase(PGH). Exp Eye Res 1981; 32: 197-204.
13. Nielsen PJ, Gregersen P, Mortensen KK, Kalstrup N. The effect of indomethacin 1 % ophthalmic suspension in preventing surgically induced miosis at extracapsular cataract surgery. Acta Ophthalmol (Copenh) 1987; 182 (suppl): S115-8.
14. Sachdev MS, Mehda MR, Dada VK, Jain AK, Garg SP, Gupta SK. Pupillary dilatation during cataract surgery-relative efficacy of indomethacin and flurbiprofen. Ophthalmic Surg 1990; 21: 557-9.
15. Stark WJ, Fagadau WR, Stewart RH, et al. Reduction of pupillary constriction during cataract surgery using suprofen. Arch Ophthalmol 1986; 104: 364-6.
16. Fraunfelder FT, Martha Mayer S. Systemic reactions to ophthalmic drug preparations. Med Toxicol 1987; 2: 287-93.
17. Solosko D, Smith RB. Hypertension following 10% phenyephrine ophthalmic. Anaesthesiology 1972; 36: 187-9.
18. Wilensky JT, Woodward HJ. Acute systemic hypertension after conjunctival instillation of phenylephrine hydrochloride. Am Ophthalmol 1973; 76: 156-7.
19. Fraunfelder FT, Scafidi MD. Possible adverse effects from topical ocular 10% phenylephrine. Am J Ophthalmol 1978; 4: 447-54.
20. Vaughan RW. Ventricular arrhythmias after topical vasoconstrictors. Anaesth Analg 1973; 52: 161-5.
21. Mc Reynolds WV, Havener WH, Henderson JW. Hazards in the use of sympathomimetic drugs in ophthalmology. Arch Ophthalmol 1956; 56: 176-9.
22. Davidson SI. Systemic effects of eye drops. Trans Ophthalmol Soc UK 1974; 94: 487-95.
23. Caputo AR, Schitzer RE. Systemic response to mydriatic eyedrops in neonates. J Pediatr Ophthalmol Strabismus 1978; 15: 109-22.
24. Duffin BM, Camrac CD, Gardner SK, et al. Inhibitors of surgically induced miosis. Ophthalmology 1982; 89: 966-79.
25. Gregersen PL, Nielsen PJ, Mortensen KK. The effect of indomethacin 1 % ophthalmic suspension on the pupil during extracapsular cataract surgery. Acta Ophthalmol 1992; 70: 522-4.
26. Gimbel HV. The effect of treatment with topical anti-inflammatory drugs with and without intraoperative epinephrine on the maintenance of mydriasis during cataract surgery. Ophthalmology 1989; 96: 585-8.
27. Koay Peter. The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology. Br J Ophthalmol 1996; 80: 480-5.
28. Asthon P, Clack DS, Lee VH. A mechanistic study on the enhancement of corneal penetration of phenylephrine by flurbiprofen in the rabbit. Curr Eye Res 1992; 11: 85-90.